Li Jing, Kang Le-Ni, Qiao You-Lin
Cancer Institute/Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Asian Pac J Cancer Prev. 2011;12(5):1149-53.
Human papillomavirus (HPV) infection is a common sexually transmitted infection (STI) worldwide. HPV may cause several reproductive tract diseases and cervical cancer is the most serious health problem due to persistent high risk HPV infection. Although cervical cancer showed a declining trend over the past three decades in China, it remains a major health problem in Chinese women especially women living in rural China. The disease burden is believed to be underestimated given the relatively high HPV prevalence shown in recent studies. To date, prophylactic vaccination as a primary prevention of cervical cancer are available in many countries and regions of the world; yet, they are not yet accessible in mainland China. Before introduction of HPV vaccines, screening remains the predominant method of prevention. Selected population based screening sites are available in every province of China, yet, an organized screening program operating nationwide still does not exist. A better understanding of the disease burden is likely to help develop a comprehensive intervention policy for future management of cervical cancer in China. It is important to review the disease burden of cervical cancer and the current status of cervical cancer screening in mainland China.
人乳头瘤病毒(HPV)感染是全球常见的性传播感染(STI)。HPV可引发多种生殖道疾病,而持续性高危HPV感染导致的宫颈癌是最严重的健康问题。尽管在过去三十年中,中国宫颈癌发病率呈下降趋势,但它仍是中国女性尤其是农村女性面临的主要健康问题。鉴于近期研究显示的相对较高的HPV感染率,该疾病负担可能被低估。迄今为止,预防性疫苗接种作为宫颈癌的一级预防措施在世界许多国家和地区都已可用;然而,中国大陆尚未引入。在引入HPV疫苗之前,筛查仍然是主要的预防方法。中国每个省份都有选定的基于人群的筛查点,但全国范围内仍未开展有组织的筛查项目。更好地了解疾病负担可能有助于制定中国未来宫颈癌管理的综合干预政策。回顾中国大陆宫颈癌的疾病负担和宫颈癌筛查现状非常重要。